Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Martin

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Open Forum Infectious Diseases|April 6, 2019
Effectiveness of Direct-Acting Antiviral Therapy in Patients With Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in Routine Clinical Care: A Multicenter StudyH Nina Kim, Robin M Nance, Jessica S Williams-Nguyen, et al.
BMC Cancer|February 8, 2016
Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi's sarcoma in five countries across sub-Saharan AfricaEsther Freeman, Aggrey Semeere, Megan Wenger, et al.
BMC Cancer|September 4, 2017
Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan AfricaAggrey Semeere, Esther Freeman, Megan Wenger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 28, 2014
Disparities in the quality of HIV care when using US Department of Health and Human Services indicatorsKeri N Althoff, Peter Rebeiro, John T Brooks, et al.
Nature Medicine|April 1, 2008
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individualsSunil K Ahuja, Hemant Kulkarni, Gabriel Catano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 8, 2022
Current Antiretroviral Treatment Among People With Human Immunodeficiency Virus in the United States: Findings from the Centers for AIDS Research Network of Integrated Clinic Systems CohortJimmy Ma, Robin M Nance, Joseph A C Delaney, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infectionAshok K Dwivedi, David A Siegel, Cassandra Thanh, et al.
Nature Communications|November 18, 2024
Rapid biphasic decay of intact and defective HIV DNA reservoir during acute treated HIV diseaseAlton Barbehenn, Lei Shi, Junzhe Shao, et al.
Journal of Virology|September 8, 2017
HLA-B*14:02-Restricted Env-Specific CD8<sup>+</sup> T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV InfectionEllen M Leitman, Christian B Willberg, Ming-Han Tsai, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Rapid Biphasic Decay of Intact and Defective HIV DNA Reservoir During Acute Treated HIV DiseaseAlton Barbehenn, Lei Shi, Junzhe Shao, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Open Forum Infectious Diseases|April 6, 2019
Effectiveness of Direct-Acting Antiviral Therapy in Patients With Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in Routine Clinical Care: A Multicenter StudyH Nina Kim, Robin M Nance, Jessica S Williams-Nguyen, et al.
BMC Cancer|February 8, 2016
Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi's sarcoma in five countries across sub-Saharan AfricaEsther Freeman, Aggrey Semeere, Megan Wenger, et al.
BMC Cancer|September 4, 2017
Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan AfricaAggrey Semeere, Esther Freeman, Megan Wenger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 28, 2014
Disparities in the quality of HIV care when using US Department of Health and Human Services indicatorsKeri N Althoff, Peter Rebeiro, John T Brooks, et al.
Nature Medicine|April 1, 2008
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individualsSunil K Ahuja, Hemant Kulkarni, Gabriel Catano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 8, 2022
Current Antiretroviral Treatment Among People With Human Immunodeficiency Virus in the United States: Findings from the Centers for AIDS Research Network of Integrated Clinic Systems CohortJimmy Ma, Robin M Nance, Joseph A C Delaney, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infectionAshok K Dwivedi, David A Siegel, Cassandra Thanh, et al.
Nature Communications|November 18, 2024
Rapid biphasic decay of intact and defective HIV DNA reservoir during acute treated HIV diseaseAlton Barbehenn, Lei Shi, Junzhe Shao, et al.
Journal of Virology|September 8, 2017
HLA-B*14:02-Restricted Env-Specific CD8<sup>+</sup> T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV InfectionEllen M Leitman, Christian B Willberg, Ming-Han Tsai, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Rapid Biphasic Decay of Intact and Defective HIV DNA Reservoir During Acute Treated HIV DiseaseAlton Barbehenn, Lei Shi, Junzhe Shao, et al.
Pageof 15